Jack Chan's Weekly Precious Metals Market Update
Source: Jack Chan for Streetwise Reports  (1/2/18)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets, noting buy signals for both gold and silver at the close of 2017.
More >

The Road Ahead for Oil
Source: Clive Maund for Streetwise Reports  (1/2/18)
Technical analyst Clive Maund charts oil and suggests that a commodities bull market may be brewing. More >

A Silver Stock Rated a Strong Buy
Source: Clive Maund for Streetwise Reports  (1/2/18)
Clive Maund conducts a technical analysis on a silver company and finds it is at a good entry point. More >

Expert Calls this Explorer a Buy
Source: Adrian Day for Streetwise Reports  (1/2/18)
Adrian Day of Adrian Day Asset Management describes why investors should consider this "well-run gold exploration company with downside protection and plenty of upside." 
More >

Copper Outlook at Critical Juncture and Implications for the Silver Price
Source: Clive Maund for Streetwise Reports  (12/30/17)
Technical analyst Clive Maund delves into the reasons behind copper's recent rise and what that could mean for silver. More >

When to Take Profits in the Cannabis Sector
Source: Clive Maund for Streetwise Reports  (12/28/17)
With a run-up in cannabis stocks, technical analyst Clive Maund shares his thoughts on when investors should take profits. More >

2017: A Year of Triple Digit Stock Performance
Source: Streetwise Reports  (12/28/17)
As stock indexes in the U.S. hit record highs in 2017, we take a look at some of the best performers profiled by Streetwise Reports in the last year, some of which have seen triple digit increases. More >

Biotech's Shares 'Undervalued' and Positioned for 'Long-Term Upside Potential'
Source: Streetwise Reports  (12/27/17)
Zacks Small-Cap Research analyst John Vandermosten reviewed the Q2 FY18 financial results for this epigenetics firm, which is moving forward with a Phase 3 trial targeting heart disease.
More >

Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA
Source: Streetwise Reports  (12/27/17)
Jason Kolbert, an analyst with Maxim Group, described the study, which enables this biotech's device to be used in patients undergoing heart surgery and will measure its effectiveness in reducing a common post-surgical side effect.
More >

Jack Chan's Weekly Precious Metals Market Update
Source: Jack Chan for Streetwise Reports  (12/27/17)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets, noting an upturn in the cycle that might indicate the end of a multimonth correction.
More >

Mining Project Financing Firm Transacts Royalty Agreement
Source: Streetwise Reports  (12/27/17)
BMO Capital Markets reported on this company's recent royalty transaction and its upside potential. More >

Michael Ballanger: CME 'Fiat Police' Arrive Right on Schedule
Source: Michael J. Ballanger for Streetwise Reports  (12/27/17)
Precious metals expert Michael Ballanger offers his take on how cryptocurrencies like Bitcoin can be affected by central banks. More >

Gold Miner Seeks Approval to Boost Mill Capacity, 'Pumping Up the Potential'
Source: Streetwise Reports  (12/27/17)
Canaccord Genuity analyst Eric Zaunscherb discussed this precious metals company's recent request to the government of British Columbia. More >

The Big Picture for Gold Is Bullish
Source: Clive Maund for Streetwise Reports  (12/26/17)
Technical analyst Clive Maund charts gold and finds that although the precious metal is being buffeted by cross currents, the big picture is bullish. More >

Silver Is a Strong Buy
Source: Clive Maund for Streetwise Reports  (12/26/17)
An analysis of silver charts leads technical analyst Clive Maund to conclude that silver should rise soon. More >

An Early-Stage Electric Vehicle Manufacturer in an Extremely High-Growth Market
Source: Streetwise Reports  (12/22/17)
Hunter Diamond, CFA, founder of Diamond Equity Research, profiles a company that he believes offers investors a unique opportunity to invest in the clean, renewable and sustainable transportation market. More >

Bitcoin, Blockchain and Gold: A Year of Disruption
Source: Streetwise Reports  (12/22/17)
While gold is perceived to have lagged in 2017, the metal is actually up about 10% for the year, notes Frank Holmes, CEO of U.S. Global Investors. In this interview with The Gold Report, Holmes discusses bitcoin and blockchain's dramatic rise, the future of precious metals investing, and companies on his short list to watch.
More >

Four Miners Advance Exploration and Development Projects
Source: Adrian Day for Streetwise Reports  (12/22/17)
Adrian Day of Adrian Day Asset Management takes a look at four companies, noting the progress made by three and reflecting on another that is "trying to salvage what it can of its best mine." More >

A Set of Firms, Including Two Prospectors, Reviewed by Asset Manager
Source: Adrian Day for Streetwise Reports  (12/22/17)
A pair of resource companies, along with another couplet of firms, prompted commentary from investment analyst Adrian Day of Adrian Day Asset Management.
More >

Prospector Picks First Exploration Target from New Acquisitions
Source: Streetwise Reports  (12/21/17)
Mike Niehuser, an analyst with Scarsdale Equities, provided background on an asset believed to be an "advanced exploration target."
More >

5 Undervalued Miners for This Tax-Loss Selling Season
Source: Streetwise Reports  (12/21/17)
As the year comes to a close, Ralph Aldis, portfolio manager of U.S. Global Investors, reviews some of his precious metals holdings and calls out a handful of companies he believes tax-loss selling has made particularly good values right now.
More >

Gold Miner Heading into the New Year with Results Above Expectations
Source: Streetwise Reports  (12/21/17)
With multiple gold exploration results coming in from its 100%-owned asset, this company is optimistic about its in-progress PEA on its Nevada property. More >

'Exciting' Collaborations Possible for Biotech's 'Flexible' Platform
Source: Streetwise Reports  (12/20/17)
Zacks Small-Cap Research's John Vandermosten discussed the potential for this immunotherapy firm's RNAi compounds in oncology. More >

Biotech Receives 'Major Endorsement from World-Leading Pharma Company'
Source: Streetwise Reports  (12/20/17)
David Kideckel, an analyst with Beacon Securities Ltd., relayed news from this firm's recent annual meeting, including a private placement with a large pharma and an update on the Phase 3 trial of its lead therapy. More >

Updates from ASH Reinforce Analyst's Big Price Target Potential
Source: Streetwise Reports  (12/20/17)
Andrew Fein, an analyst with H.C. Wainwright & Co., discussed the implications of this biopharmaceutical's recently announced data, which support his "bullish" outlook for the firm's candidate in chronic graft versus host disease.
More >